The burden of cognitive decline is growing, affecting many people worldwide and placing a substantial strain on health-care ...

The U.S. Food and Drug Administration has cleared another blood test that could help doctors identify whether memory problems ...

A new companion to the GSA KAER Toolkit for Brain Health helps clinicians and caregivers promote brain health, detect cognitive changes early, and support adults with intellectual and developmental ...

The test is intended for adults 55 and older in the United States who are showing signs or symptoms of cognitive decline.

The FDA has cleared Roche's Elecsys pTau181 test, a blood-based biomarker test for Alzheimer's disease, allowing for earlier ...

Researchers found that even limited social media use can hurt children’s ability to focus and retain information—echoing what ...

While discussing his plans for a physical, President Trump once again bragged about the score he achieved on his last cognitive assessment.

For the first time, a study shows an online assessment can provide a scientific measure of acetylcholine – a key brain chemical, which declines progressively with cognitive aging and even more quickly ...

Researchers have identified a new subtype of multiple sclerosis that affects thinking and memory rather than mobility — and as many as 26 percent of people with MS may have it. Researchers have ...

New study findings could make it easier to diagnose Alzheimer’s and related dementias, particularly in underrepresented populations Blood tests are emerging as a potential diagnostic tool for ...